Home|Journals Follow on Twitter| Subscribe to List

Directory for Medical Articles

Open Access


IJHSR. 2013; 3(12): 69-74

Evaluation of Myeloperoxidase in Saudi Patients with Chronic Renal Failure.

Ahmed Mohammed Ahmed, Kamal Eldin Hussein Elhassan, Hussein Yousif Abdallah, Bader Eldien Hassan Elabid.

Objective: Evaluation of Myeloperoxidase (MPO) enzyme in Saudi patients with chronic renal failure (CRF), compared with control healthy subjects.
Back ground: The patients with renal failure are at a risk for cardiovascular diseases (CVD), MPO is a pro-oxidant enzyme, and through its strongest oxidative capacity suggested have a role in protection against CVD. In this study the level of MPO enzyme was expected to decrease in patients with CRF compared with control healthy subjects which mean that they were more vulnerable to CVD.
Methods: A case control investigated of MPO enzyme and renal function tests (urea and creatinine) levels in renal failure patients compared with a healthy subjects. Plasma MPO was assayed by a spectrophotometric method. Serum urea and creatinine were estimated on a clinical chemistry analyzer using standard laboratory procedures.
Results: The mean MPO level was significantly decreased in CRF patients compared to control healthy subjects (t=-23.737) (99% confidence intervals and t-test-23.737 significant at P < 0.01). There were significant positive correlation between MPO and Glomerular Filtration Ratio (GFR) (r=0.657, P < 0.01) and significant inverse correlation with Urea (r=-.729, P < 0.01) and Creatinine (r=-0.772, P < 0.01). No correlations observed in control healthy subjects (P = 0.97).
Conclusion: The level of MPO was significantly decreased in patients with CRF, this decreased may be due to inhibition of uremic toxins.

Key words: Oxidative stress, Uraemic toxins, Cardiovascular disease (CVD).

Share this Article

Progress in Orthopedic Science


ScopeMed Home
Follow ScopeMed on Twitter
Author Tools
eJPort Journal Hosting
About ScopeMed
License Information
Terms & Conditions
Privacy Policy
Suggest a Journal
Publisher Login
Contact Us

The articles in Scopemed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Database Service for Scientific Publications. Copyright ScopeMed Information Services.
Scopemed Buttons